Cases 11 - 20 of 51
HORIZON THERAPEUTICS, LLC v. TARO PHARMACEUTICAL INDUSTRIES LTD. et al
as 1:2022cv04663
Plaintiff:
HORIZON THERAPEUTICS, LLC
Defendant:
TARO PHARMACEUTICAL INDUSTRIES LTD. and TARO PHARMACEUTICALS, U.S.A., INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation
as 1:2021md03017
In Re:
Xarelto (Rivaroxaban) ('310) Patent Litigation
Not Classified By Court:
Clerk of MDL Panel, Lupin Limited, Lupin Pharmaceuticals, Inc. and others
Counter Defendant:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Taro Pharmaceutical Industries Ltd. et al v. Encube Ethicals Pvt. Ltd.
as 1:2021cv01614
Counter Defendant:
Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals North America, Inc. and Taro Pharmaceuticals U.S.A., Inc.
Defendant:
Encube Ethicals Pvt. Ltd.
Cause Of Action: 35 U.S.C. § 1
Bayer Pharma AG et al v. Taro Pharmaceutical Industries Ltd. et al
as 1:2021cv01000
Plaintiff:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.
Cause Of Action: 35 U.S.C. § 271
BAUSCH HEALTH US, LLC et al v. TARO PHARMACEUTICALS U.S.A., INC. et al
as 3:2020cv02747
Plaintiff:
BAUSCH HEALTH IRELAND LIMITED, KAKEN PHARMACEUTICAL CO., LTD., BAUSCH HEALTH US, LLC and others
Defendant:
TARO PHARMACEUTICALS U.S.A., INC., TARO PHARMACEUTICAL INDUSTRIES LTD. and TARO PHARMACEUTICALS INC.
Cause Of Action: 35 U.S.C. § 271
In re: Kerydin (Tavaborole) Topical Solution 5% Patent Litigation
as 1:2019md02884
Counter Claimant:
Glasshouse Pharmaceuticals Limited Canada
Not Classified By Court:
Taro Pharmaceuticals U.S.A., Inc., Aurobindo Pharma Limited, Zydus Pharmaceuticals (USA) Inc. and others
In Re:
Kerydin (Tavaborole) Topical Solution 5% Patent Litigation
Counter Defendant:
Anacor Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Leo Pharma A/S et al v. Taro Pharmaceuticals U.S.A., Inc. et al
as 1:2019cv01051
Plaintiff:
Leo Pharma A/S, Foamix Pharmaceuticals Ltd. and Leo Pharma, Inc.
Defendant:
Taro Pharmaceuticals U.S.A., Inc. and Taro Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271
LEO Pharma A/S et al v. Taro Pharmaceuticals U.S.A. et al
as 1:2019cv00221
Defendant:
Taro Pharmaceutical Industries, Ltd. and Taro Pharmaceuticals U.S.A.
Plaintiff:
LEO Pharma A/S, Foamix Pharmaceuticals Ltd. and LEO Pharma Inc.
Cause Of Action: 35 U.S.C. § 271
TARO PHARMACEUTICAL INDUSTRIES LTD. et al v. NOVITIUM PHARMA, LLC
as 3:2019cv01028
Plaintiff:
TARO PHARMACEUTICALS U.S.A., INC., TARO PHARMACEUTICAL INDUSTRIES LTD. and TARO PHARMACEUTICALS NORTH AMERICA, INC.
Defendant:
NOVITIUM PHARMA, LLC
Cause Of Action: 35 U.S.C. § 271
Merz Pharmaceuticals, LLC et al v. Suven Life Sciences, Ltd. et al
as 5:2018cv00584
Plaintiff:
Merz Pharmaceuticals, LLC and Merz North America, Inc.
Defendant:
Suven Life Sciences, Ltd., Taro Pharmaceuticals U.S.A., Inc. and Taro Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
